Christopher D Hillyer

InstitutionNew York Blood Center
AddressNew York
New York
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 11 Covid-19 publications, with a maximum of 2 publications in April 2020 and August 2020
    All Publications
    Bar chart showing 110 publications over 19 distinct years, with a maximum of 16 publications in 2009
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Nesbitt DJ, Jin DP, Hogan JW, Yang J, Chen H, Chan PA, Simon MJ, Vargas M, King E, Huard RC, Bandy U, Hillyer CD, Luchsinger LL. Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats. BMC Infect Dis. 2021 Aug 25; 21(1):871. PMID: 34433423.
      Citations: 1     Fields:    Translation:Humans
    2. Jin DK, Nesbitt DJ, Yang J, Chen H, Horowitz J, Jones M, Vandergaast R, Carey T, Reiter S, Russell SJ, Kyratsous C, Hooper A, Hamilton J, Ferreira M, Deng S, Straus D, Baras A, Hillyer CD, Luchsinger LL. Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening". PLoS One. 2021; 16(4):e0250319. PMID: 33909646.
      Citations:    Fields:    Translation:Humans
    3. Luchsinger LL, Hillyer CD. Vaccine efficacy probable against COVID-19 variants. Science. 2021 03 12; 371(6534):1116. PMID: 33707257.
      Citations: 8     Fields:    Translation:Humans
    4. Curreli F, Victor SMB, Ahmed S, Drelich A, Tong X, Tseng CK, Hillyer CD, Debnath AK. Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro. mBio. 2020 12 11; 11(6). PMID: 33310780.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    5. Luchsinger LL, Ransegnola BP, Jin DK, Muecksch F, Weisblum Y, Bao W, George PJ, Rodriguez M, Tricoche N, Schmidt F, Gao C, Jawahar S, Pal M, Schnall E, Zhang H, Strauss D, Yazdanbakhsh K, Hillyer CD, Bieniasz PD, Hatziioannou T. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients. J Clin Microbiol. 2020 11 18; 58(12). PMID: 32917729.
      Citations: 60     Fields:    Translation:HumansCellsPHPublic Health
    6. Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JC, Muecksch F, Rutkowska M, Hoffmann HH, Michailidis E, Gaebler C, Agudelo M, Cho A, Wang Z, Gazumyan A, Cipolla M, Luchsinger L, Hillyer CD, Caskey M, Robbiani DF, Rice CM, Nussenzweig MC, Hatziioannou T, Bieniasz PD. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Elife. 2020 10 28; 9. PMID: 33112236.
      Citations: 367     Fields:    Translation:HumansCells
    7. Ragnesola B, Jin D, Lamb CC, Shaz BH, Hillyer CD, Luchsinger LL. COVID19 antibody detection using lateral flow assay tests in a cohort of convalescent plasma donors. BMC Res Notes. 2020 Aug 06; 13(1):372. PMID: 32762746.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    8. Tai W, Zhang X, Drelich A, Shi J, Hsu JC, Luchsinger L, Hillyer CD, Tseng CK, Jiang S, Du L. A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2. Cell Res. 2020 10; 30(10):932-935. PMID: 32759966.
      Citations: 36     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    9. Budhai A, Wu AA, Hall L, Strauss D, Paradiso S, Alberigo J, Hillyer CD, Jett B, Tobian AAR, Bloch EM, Sachais BS, Shaz BH. How did we rapidly implement a convalescent plasma program? Transfusion. 2020 07; 60(7):1348-1355. PMID: 32449169.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    10. Jiang S, Hillyer C, Du L. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355-359; 2020). Trends Immunol. 2020 06; 41(6):545. PMID: 32362491.
      Citations: 44     Fields:    
    11. Jiang S, Hillyer C, Du L. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses. Trends Immunol. 2020 05; 41(5):355-359. PMID: 32249063.
      Citations: 287     Fields:    Translation:HumansCellsPHPublic Health
    Hillyer's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (166)
    Explore
    _
    Co-Authors (87)
    Explore
    _
    Similar People (60)
    Explore
    _